Gp. Kurzban et al., Sulfhemoglobin formation in human erythrocytes by cystalysin, an L-cysteine desulfhydrase from Treponema denticola, ORAL MICROB, 14(3), 1999, pp. 153-164
Cystalysin, isolated from the oral pathogen Treponema denticola, is an L-cy
steine desulfhydrase (producing pyruvate, ammonia and hydrogen sulfide from
cysteine) that can modify hemoglobin and has hemolytic activity. Here, we
show that enzymatic activity of recombinant cystalysin depends upon stochio
metric pyridoxal phosphate. The enzyme was not functional as an L-alanine t
ransaminase, and had a strong preference for L-cysteine over D-cysteine. Cy
stalysin preferred small alpha-L-amino acids as substrates or inhibitors an
d was far more active towards L-cysteine than towards the other standard am
ino acids that undergo pyridoxal phosphate-dependent beta-elimination react
ions (serine, threonine, tryptophan and tyrosine). Cystalysin tolerated sma
ll modifications to the carboxylate of L-cysteine (i.e., the methyl and eth
yl esters of L-cysteine were good substrates), but the smallest possible pe
ptide with an N-terminal cysteine, L-cysteinylglycine, was a very poor subs
trate. These results, combined with the implicit requirement for a free ami
ne for pyridoxal phosphate-dependent reactions, imply that cystalysin canno
t catabolize cysteine residues located within peptides. Cystalysin has Mich
aelis-Menten kinetics towards L-cysteine, and there was little or no inhibi
tion by ammonia, H2S, pyruvate and acetate. Human erythrocytes incubated wi
th H2S or with cystalysin and cysteine primarily accumulated sulfhemoglobin
and methemoglobin, along with minor amounts of choleglobin and protein agg
regates. Erythrocytes retained the ability to reduce methemoglobin in the p
resence of H2S. Cystalysin could not modify hemoglobin when beta-chloroalan
ine was the substrate, indicating an absolute requirement for H2S productio
n. Cystalysin appears to be an unregulated L-cysteine catabolizing enzyme,
with the resulting H2S production being essential to the atypical hemolytic
activity.